ONMD Stock Risk & Deep Value Analysis
Onemednet Corp
Healthcare • Health Information Services
DVR Score
out of 10
What You Need to Know About ONMD Stock
We analyzed Onemednet Corp using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran ONMD through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
How Risky Is ONMD Stock?
Overall Risk
Aggressive
Financial Risk
High
Market Risk
Medium
Competitive Risk
High
Execution Risk
High
Regulatory Risk
Medium
What Are the Red Flags for ONMD?
- âš
Failure to secure additional financing, leading to liquidity crisis or bankruptcy
- âš
Further equity dilution at depressed valuations
- âš
Continued negative earnings and widening losses in Q1 2026 report
- âš
Increased competitive pressure from larger, better-funded incumbents or new entrants
Unlock ONMD Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does Onemednet Corp (ONMD) Do?
Market Cap
$64.97M
Sector
Healthcare
Industry
Health Information Services
Employees
22
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. The company offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets; and BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headquartered in Eden Prairie, Minnesota.
Visit Onemednet Corp WebsiteIs ONMD Stock Undervalued?
Unlock the full AI analysis for ONMD
Get the complete DVR score, risk analysis, and more
Does ONMD Have a Competitive Moat?
Sign in to unlockMoat Rating
⚪ None
Moat Trend
Eroding
Moat Sources
2 Identified
The company's nascent 'moat' is extremely fragile and easily replicated or surpassed by larger, better-funded competitors with superior resources, technology, and sales channels. Without significant scale and proven differentiation, any potential advantage is ephemeral.
Moat Erosion Risks
- •Inability to achieve sufficient scale to create network effects or meaningful switching costs
- •Competitors developing superior or cheaper iRWD solutions
- •Lack of funding to invest in IP protection and R&D
ONMD Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive ONMD Stock Higher?
Near-Term (0-6 months)
- •Q1 2026 Earnings Report (estimated early May 2026)
- •Announcement of a new, small-scale pilot project or partnership
Medium-Term (6-18 months)
- •Securing a significant institutional funding round (critical for survival)
- •Demonstrated acceleration in iRWD platform adoption or data licensing agreements
- •Strategic partnership with a major pharmaceutical or life sciences company
Long-Term (18+ months)
- •Widespread industry adoption of iRWD as a standard for drug development and clinical trials
- •Achieving a sustainable, profitable business model and positive cash flow
- •Expansion of regulatory acceptance for RWD/iRWD in drug approvals
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for ONMD?
- ✓
Confirmation of a significant, non-dilutive financing round (e.g., strategic investment from a major pharma partner)
- ✓
Quarterly revenue growth exceeding 50% year-over-year for at least two consecutive quarters
- ✓
Demonstrable progress towards positive operating cash flow and reduced cash burn
- ✓
Announcement of multiple new, high-value data partnerships or customer contracts
Bull Case Analysis
See what could go right with Premium
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for ONMD (Onemednet Corp) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.


